Singapore markets closed

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6800-0.0400 (-1.08%)
At close: 04:00PM EDT
3.6800 0.00 (0.00%)
After hours: 05:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
54,807
54,807
113,323
90,622
35,973
Selling general and administrative
48,895
48,895
47,926
35,082
24,866
Total operating expenses
103,702
103,702
161,249
125,703
60,839
Operating income or loss
-103,702
-103,702
-161,249
-125,703
-60,839
Total other income/expenses net
-241.157
-241.157
1,546
-1,247
-16.946
Income before tax
-98,792
-98,792
-157,044
-125,752
-59,456
Income from continuing operations
-98,792
-98,792
-157,044
-125,752
-59,456
Net income
-98,792
-98,792
-157,044
-125,752
-59,456
Net income available to common shareholders
-98,792
-98,792
-157,044
-125,752
-59,456
Basic EPS
-1.33
-3.28
-5.30
-7.16
-3.81
Diluted EPS
-1.33
-3.28
-5.30
-7.16
-3.81
Basic average shares
9,217
30,099
29,629
17,553
15,594
Diluted average shares
9,217
30,099
29,629
17,553
15,594